Facultad de Fisioterapia-Universidade de Vigo
Pontevedra, España, 36005, Spain
NCT Number: NCT07143721
This pilot study aims to evaluate how the diaphragm responds to different inspiratory muscle training loads using ultrasound in healthy individuals. The observational, cross-sectional research seeks to determine whether ultrasound measurements of diaphragm movement and thickness can more effectively guide load prescription, thereby optimizing the benefits of inspiratory training. Twenty healthy participants, of both sexes, aged 18 to 35 years, will be recruited through outreach at the Faculty of Physiotherapy at the University of Vigo. The assessment will include spirometry, maximum inspiratory pressure (MIP) measurement, and ultrasound evaluations of the diaphragm at various loads (10%, 30%, 50%, and 70% of the MIP). Data will be analyzed to understand how diaphragm mobility, thickness, and contraction velocity vary according to load, with the goal of improving training prescription and adjustment. The study adheres to the ethical principles of the Declaration of Helsinki and ensures strict confidentiality and participant anonymity. The results will contribute to the understanding of non-invasive diaphragm assessment and its role in enhancing respiratory and physical performance.
This study is active but is not currently recruiting participants.
18 year–35 year
All sexes
Observational
Pontevedra, España, 36005, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Healthy adults aged 18 to 35 years
No history of neuromuscular, cardiovascular, respiratory, or musculoskeletal diseases that could limit participation
Not currently on medication affecting muscle function
Willing to provide informed consent
Exclusion criteria
Pregnant women
Recent thoracic or abdominal trauma (within the last 3 months)
Respiratory symptoms in the last two weeks
Conditions preventing performing forced inspiratory maneuvers
Recent respiratory muscle training (within the last 6 months)
Time frame: Day 2: Baseline; Immediately after 10% MIP; Immediately after 30% MIP; Immediately after 50% MIP; Immediately after 70% MIP
Assessment of diaphragmatic excursion using ultrasound at 10%, 30%, 50%, and 70% of maximum inspiratory pressure (MIP). Evaluates the diaphragm's mobility as a primary measure of functional response to different inspiratory loads in healthy individuals.
Time frame: Day 2: Baseline; Immediately after 10% MIP; Immediately after 30% MIP; Immediately after 50% MIP; Immediately after 70% MIP
Measurement of diaphragmatic thickness using ultrasound at 10%, 30%, 50%, and 70% of maximum inspiratory pressure (MIP). This evaluates muscular response and mobility related to varying inspiratory efforts in healthy subjects.
Time frame: Day 2: Baseline; Immediately after 10% MIP; Immediately after 30% MIP; Immediately after 50% MIP; Immediately after 70% MIP
Assessment of diaphragmatic contraction velocity using ultrasound at 10%, 30%, 50%, and 70% of MIP. Evaluates muscular response and mobility during inspiratory efforts.
Time frame: Day 1: Spirometry session, prior to ultrasound evaluations. Day 2: Ultrasound evaluations: Baseline (reposo, pre-load); Immediately after 10% PIM; Immediately after 30% PIM; Immediately after 50% PIM; Immediately after 70% PIM.
Analysis of the relationship between ultrasound measurements of diaphragmatic function (excursion, thickness, and contraction velocity) and spirometry parameters (such as FEV1, FVC, PEF) obtained in a separate session, to evaluate how ultrasound indicators reflect overall respiratory capacity in healthy individuals.
University of Vigo
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736599
Behavior, Behavioral Symptoms
Amasya, Turkey (Türkiye)
View Trial DetailsNCT00410241
Arterial Occlusive Diseases, Arteriosclerosis
Bethesda, Maryland, United States
View Trial DetailsNCT07646548
Healthy Volunteers
Hialeah, Florida, United States
View Trial DetailsNCT07567781
Healthy Volunteers
Grayslake, Illinois, United States
View Trial Details